These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 35476174)

  • 21. Selective peroxisome proliferator-activated receptor-α modulator K-877 efficiently activates the peroxisome proliferator-activated receptor-α pathway and improves lipid metabolism in mice.
    Takei K; Han SI; Murayama Y; Satoh A; Oikawa F; Ohno H; Osaki Y; Matsuzaka T; Sekiya M; Iwasaki H; Yatoh S; Yahagi N; Suzuki H; Yamada N; Nakagawa Y; Shimano H
    J Diabetes Investig; 2017 Jul; 8(4):446-452. PubMed ID: 28084058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peroxisome proliferator-activated receptor (PPAR)-gamma positively controls and PPARalpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARbeta/delta via mutual control of PPAR expression levels.
    Aleshin S; Grabeklis S; Hanck T; Sergeeva M; Reiser G
    Mol Pharmacol; 2009 Aug; 76(2):414-24. PubMed ID: 19483106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acquired Glucocorticoid Resistance Due to Homologous Glucocorticoid Receptor Downregulation: A Modern Look at an Age-Old Problem.
    Spies LL; Verhoog NJD; Louw A
    Cells; 2021 Sep; 10(10):. PubMed ID: 34685511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reciprocal regulation of brain and muscle Arnt-like protein 1 and peroxisome proliferator-activated receptor alpha defines a novel positive feedback loop in the rodent liver circadian clock.
    Canaple L; Rambaud J; Dkhissi-Benyahya O; Rayet B; Tan NS; Michalik L; Delaunay F; Wahli W; Laudet V
    Mol Endocrinol; 2006 Aug; 20(8):1715-27. PubMed ID: 16556735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential effects on lung cancer cell proliferation by agonists of glucocorticoid and PPARα receptors.
    Liang H; Kowalczyk P; Junco JJ; Klug-De Santiago HL; Malik G; Wei SJ; Slaga TJ
    Mol Carcinog; 2014 Sep; 53(9):753-63. PubMed ID: 23625588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of peroxisome proliferator-activated receptor-alpha expression during lung inflammation.
    Becker J; Delayre-Orthez C; Frossard N; Pons F
    Pulm Pharmacol Ther; 2008; 21(2):324-30. PubMed ID: 17897854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of peroxisome proliferator-activated receptor-alpha and -gamma agonists on 11beta-hydroxysteroid dehydrogenase type 1 in subcutaneous adipose tissue in men.
    Wake DJ; Stimson RH; Tan GD; Homer NZ; Andrew R; Karpe F; Walker BR
    J Clin Endocrinol Metab; 2007 May; 92(5):1848-56. PubMed ID: 17327378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucocorticoid exposure in late gestation permanently programs rat hepatic phosphoenolpyruvate carboxykinase and glucocorticoid receptor expression and causes glucose intolerance in adult offspring.
    Nyirenda MJ; Lindsay RS; Kenyon CJ; Burchell A; Seckl JR
    J Clin Invest; 1998 May; 101(10):2174-81. PubMed ID: 9593773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic potential of the dual peroxisome proliferator activated receptor (PPAR)α/γ agonist aleglitazar in attenuating TNF-α-mediated inflammation and insulin resistance in human adipocytes.
    Massaro M; Scoditti E; Pellegrino M; Carluccio MA; Calabriso N; Wabitsch M; Storelli C; Wright M; De Caterina R
    Pharmacol Res; 2016 May; 107():125-136. PubMed ID: 26976796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chromatin recruitment of activated AMPK drives fasting response genes co-controlled by GR and PPARα.
    Ratman D; Mylka V; Bougarne N; Pawlak M; Caron S; Hennuyer N; Paumelle R; De Cauwer L; Thommis J; Rider MH; Libert C; Lievens S; Tavernier J; Staels B; De Bosscher K
    Nucleic Acids Res; 2016 Dec; 44(22):10539-10553. PubMed ID: 27576532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estrogen-related receptor alpha directs peroxisome proliferator-activated receptor alpha signaling in the transcriptional control of energy metabolism in cardiac and skeletal muscle.
    Huss JM; Torra IP; Staels B; Giguère V; Kelly DP
    Mol Cell Biol; 2004 Oct; 24(20):9079-91. PubMed ID: 15456881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
    Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
    Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CLOCK is involved in the circadian transactivation of peroxisome-proliferator-activated receptor alpha (PPARalpha) in mice.
    Oishi K; Shirai H; Ishida N
    Biochem J; 2005 Mar; 386(Pt 3):575-81. PubMed ID: 15500444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo and ex vivo regulation of breast cancer resistant protein (Bcrp) by peroxisome proliferator-activated receptor alpha (Pparα) at the blood-brain barrier.
    Hoque MT; Shah A; More V; Miller DS; Bendayan R
    J Neurochem; 2015 Dec; 135(6):1113-22. PubMed ID: 26465636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impairments of hepatic gluconeogenesis and ketogenesis in PPARα-deficient neonatal mice.
    Cotter DG; Ercal B; d'Avignon DA; Dietzen DJ; Crawford PA
    Am J Physiol Endocrinol Metab; 2014 Jul; 307(2):E176-85. PubMed ID: 24865983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The glucocorticoid receptor and the orphan nuclear receptor chicken ovalbumin upstream promoter-transcription factor II interact with and mutually affect each other's transcriptional activities: implications for intermediary metabolism.
    De Martino MU; Bhattachryya N; Alesci S; Ichijo T; Chrousos GP; Kino T
    Mol Endocrinol; 2004 Apr; 18(4):820-33. PubMed ID: 14739255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11beta-hydroxysteroid dehydrogenase type 1 null mice.
    Morton NM; Holmes MC; Fiévet C; Staels B; Tailleux A; Mullins JJ; Seckl JR
    J Biol Chem; 2001 Nov; 276(44):41293-300. PubMed ID: 11546766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of peroxisome proliferator-activated receptor alpha--independent effects of PPARalpha activators in the rodent liver: di-(2-ethylhexyl) phthalate also activates the constitutive-activated receptor.
    Ren H; Aleksunes LM; Wood C; Vallanat B; George MH; Klaassen CD; Corton JC
    Toxicol Sci; 2010 Jan; 113(1):45-59. PubMed ID: 19850644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peroxisome proliferator-activated receptor alpha physically interacts with CCAAT/enhancer binding protein (C/EBPbeta) to inhibit C/EBPbeta-responsive alpha1-acid glycoprotein gene expression.
    Mouthiers A; Baillet A; Deloménie C; Porquet D; Mejdoubi-Charef N
    Mol Endocrinol; 2005 May; 19(5):1135-46. PubMed ID: 15661831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of the human glucocorticoid receptor alpha and beta isoforms inhibits AP-1 and NF-kappaB activities hormone independently.
    Gougat C; Jaffuel D; Gagliardo R; Henriquet C; Bousquet J; Demoly P; Mathieu M
    J Mol Med (Berl); 2002 May; 80(5):309-18. PubMed ID: 12021843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.